Compare stocks

Financière de Tubize SA is a Belgian holding company established in 1928, serving as the reference shareholder of UCB, a global biopharmaceutical company. Its sole investment is a significant stake in UCB, focusing on long-term value creation through active participation in UCB's strategic decisions. Headquartered in Brussels, Belgium, the company embodies strong family and entrepreneurial values, uniting descendants of UCB's founder, Emmanuel Janssen, and like-minded investors. This strategic positioning provides UCB with the stability necessary for sustained growth and investment in new products for patients with serious illnesses.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.